Home/Filings/4/0001209191-21-003597
4//SEC Filing

Maloberti Renaud Bertrand 4

Accession 0001209191-21-003597

CIK 0001681682other

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 4:18 PM ET

Size

6.4 KB

Accession

0001209191-21-003597

Insider Transaction Report

Form 4
Period: 2021-01-12
Maloberti Renaud Bertrand
Chief Commercial Officer
Transactions
  • Sale

    Common Stock

    2021-01-12$1.05/sh6,304$6,61915,276 total
  • Sale

    Common Stock

    2021-01-13$1.10/sh13,696$15,0661,580 total
Footnotes (1)
  • [F1]Represents shares sold pursuant to a Rule 10b5-1 trading plan.

Issuer

ENDRA Life Sciences Inc.

CIK 0001681682

Entity typeother

Related Parties

1
  • filerCIK 0001744025

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 4:18 PM ET
Size
6.4 KB